1933 Industries Inc. is a cannabis company focused on cultivating and producing cannabis products in the U.S. and Canada. While it has a gross margin of 24.7%, indicating some profitability, its overall financial health is concerning with a low score of 24/100, a current ratio of 0.90, and a quick ratio of 0.44, suggesting liquidity issues. The market cap of $5.21M and a share price of $0.01 reflect significant valuation challenges, raising questions about the company's long-term viability despite its operational potential.
Loading financial metrics...
Debt of $17.4M is 42.8x the company's cash position of $406K.
Gross margin expanded by 16.9 percentage points, indicating improved pricing power or cost efficiency.
Operating cash flow surged 44.2% YoY, indicating strong cash generation capability.
Operating cash flow of $2.2M exceeds net income by 340%, indicating high-quality earnings with strong cash conversion.
Free cash flow increased 44.2% YoY, enhancing capital allocation optionality.
Strong free cash flow margin of 12.8% provides substantial resources for dividends, buybacks, or reinvestment.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Drug Manufacturers - Specialty & Generic companies of a similar size
Based on 2026-Q1 (October 31, 2025)